Crewe Advisors’s Exelixis EXEL Stock Holding History

Crewe Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38	Closed	-$1K	–	1106
2022 Q3	$1K	Buy	+38	New	+$734	﹤0.01%	1137

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Crewe Advisors's EXEL Position: Q4 2022 in Review

Crewe Advisors sold out of Exelixis (EXEL) in Q4 2022, closing a stake of 38 shares — an estimated $1K sold.

Crewe Advisors first reported a position in EXEL in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 386 funds tracked by Wall St. Rank hold EXEL as of Q4 2022.

Crewe Advisors reported no remaining Exelixis position as of Q4 2022 after selling out during the quarter.
Crewe Advisors sold 38 Exelixis shares in Q4 2022, an estimated $1K.
Crewe Advisors first reported a position in Exelixis in Q3 2022 and held it in 1 quarter.
Crewe Advisors's Exelixis position peaked at $1K in Q3 2022.
386 funds tracked by Wall St. Rank held Exelixis as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.